Cargando…
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys
X-linked inherited ornithine transcarbamylase deficiency (OTCD) is the most common disorder affecting the liver-based urea cycle, a pathway enabling detoxification of nitrogen waste and endogenous arginine biosynthesis. Patients develop acute hyperammonemia leading to neurological sequelae or death...
Autores principales: | Baruteau, Julien, Cunningham, Sharon C., Yilmaz, Berna Seker, Perocheau, Dany P., Eaglestone, Simon, Burke, Derek, Thrasher, Adrian J., Waddington, Simon N., Lisowski, Leszek, Alexander, Ian E., Gissen, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517016/ https://www.ncbi.nlm.nih.gov/pubmed/34703837 http://dx.doi.org/10.1016/j.omtm.2021.09.005 |
Ejemplares similares
-
Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency
por: Seker Yilmaz, Berna, et al.
Publicado: (2023) -
Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort
por: Perocheau, Dany P., et al.
Publicado: (2019) -
Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency
por: Ibrahim, Majitha Seyed, et al.
Publicado: (2023) -
Three-Country Snapshot of Ornithine Transcarbamylase Deficiency
por: Seker Yilmaz, Berna, et al.
Publicado: (2022) -
Liver transplantation in ornithine transcarbamylase deficiency: A retrospective multicentre cohort study
por: Seker Yilmaz, Berna, et al.
Publicado: (2023)